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Abstract
Background: Young people with sickle cell disease (SCD) often demonstrate low medication adherence and low motivation
for effectively self-managing their condition. The growing sophistication of mobile phones and their popularity among young
people render them a promising platform for increasing medication adherence. However, so far, few apps targeting SCD have
been developed from research with the target population and underpinned with theory and evidence.
Objective: The aim of this study was to develop a theory-and-evidence-based medication adherence app to support children
and adolescents with SCD.
Methods: The Behavior Change Wheel (BCW), a theoretically based intervention development framework, along with a review
of the literature, 10 interviews with children and adolescents with SCD aged between 12 and 18 years, and consultation with
experts informed app development. Thematic analysis of interviews provided relevant theoretical and evidence-based components
to underpin the design and development of the app.
Results: Findings suggested that some patients had lapses in memory for taking their medication (capability); variation in beliefs
toward the effectiveness of medication and confidence in self-managing their condition (motivation); a limited time to take
medication; and barriers and enablers within the changing context of social support during the transition into adulthood (opportunity).
Steps were taken to select the appropriate behavioral change components (involving behavior change techniques [BCTs] such as
information on antecedents, prompts/cues; self-monitoring of the behavior; and social support) and translate them into app features
designed to overcome these barriers to medication adherence.
Conclusions: Patients with SCD have complex barriers to medication adherence necessitating the need for comprehensive
models of behavior change to analyze the problem. Children and adolescents require an app that goes beyond simple medication
reminders and takes into account the patient’s beliefs, emotions, and environmental barriers to medication adherence.
(JMIR Mhealth Uhealth 2019;7(6):e8130)  doi: 10.2196/mhealth.8130
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Introduction
Sickle Cell Disease—A Global Health Priority
Sickle cell disease (SCD) is among the most prevalent hereditary
blood disorders in the world [1], leading the World Health
Organization to prioritize it as a global health issue in 2006 and
2010. SCD causes red blood cells to become sickle-shaped
which restricts the flow of blood and the transportation of
oxygen [2]. Life-threatening complications include infections,
acute chest syndrome, stroke, and multiorgan failure [3].
However, by far, the most frequent complications are acute
vaso-occlusive events resulting in severe pain episodes. The
episodes (also known as pain crises) are predominantly managed
within the home environment but require hospitalization when
there are complications or when the pain becomes too great [4].
In the past decade, several new medications have been
developed to improve the duration and quality of patients’ lives
[5], resulting in medication adherence becoming fundamental
to patients’ self-management of their condition. However,
systematic review evidence indicates that medication adherence
is moderate among children and adolescents [5]. Poor adherence
results in reduced effectiveness of medication, increased
susceptibility to complications, and medication wastage [6,7].
It is paramount that health care professionals support young
patients in developing autonomy and self-management skills
[8]. The challenge globally is the serious shortage of health care
services to provide support for patients with SCD. The rising
migrant populations necessitate the need now more than ever
to provide accessible services despite language, culture,
finances, ethnicity, and geolocation. Consequently, this has led
to growing interest in developing tailored electronic health
technologies to support the day-to-day needs of patients.
Research has demonstrated an increase in medication adherence
among children using short message service (SMS) technology
[2], whereas other research has achieved a medication adherence
rate of 93% by using electronic directly observed therapy [9].
Sickle Cell Disease Mobile Health Apps
Mobile health (mHealth) apps offer state-of-the-art approaches
to intervention design, delivery and diffusion of treatment and
prevention efforts [10]. Key behavior change techniques (BCTs)
important for self-management are optimized through this
medium, such as self-monitoring techniques [11], which
continue to increase in sophistication [12]. So far, there is
growing evidence related to the acceptability and usability of
SCD apps aimed at monitoring various symptoms such as pain
and fatigue [13-15] and enabling medication reminders [9,16].
They can also enhance communication with health care
providers, provide general health management [14], and provide
therapeutic interventions such as cognitive behavioral therapy
[17,18]. A recent systematic review [19] reported the efficacy
of 1 mobile app feasibility study in improving medication
adherence after a 6-month follow-up [20]. However, more
research is needed to evaluate the mobile app’s efficacy and
effectiveness for self-managing SCD using careful methods and
theoretical underpinnings [19].
A 2013 Cochrane review of asthma self-management apps [21]
concluded that future app-based interventions should be
underpinned with relevant theoretical frameworks to identify
the impact of individual app features on patient outcomes [19].
However, a recent content analysis of 166 medication adherence
apps showed that the use of evidence-based BCTs were low
[22]. According to Carpenter et al, development of app features
that truly implement theoretical constructs remains an
undeveloped area, and most medication adherence and disease
management apps fail to report any theoretical underpinnings
[23], including SDC apps [21,24]. A mobile app is a
cost-effective health care intervention [25,26] to support
patients’ medication adherence. Therefore, this study aimed to
develop a theory and evidence-based medication adherence app
for children and adolescents with SCD.
Intervention Development Framework
The Behavior Change Wheel (BCW), a theoretically based
intervention development framework, was used to guide app
development [27]. The BCW is coherent, grounded in a model
of behavior (described in the Methods section), and inclusive
of all possible intervention strategies. The research draws on a
core component of the BCW: the Capability Opportunity,
Motivation-Behaviour (COM-B) model that helps to identify
important levers for change for the new behavior to occur. It
then uses the next steps in intervention development to help
bring about change in the new behavior through identifying
intervention functions (IFs) and BCTs.
The BCW framework accepts that behavior can essentially
derive from a combination of theoretical components within a
behavioral system [27]. The research also draws on the next
layers of the wheel, IFs, which are defined as expansive
classifications through which an intervention can modify
behavior [27]. The 9 IFs identified are as follows: education
(increasing knowledge or comprehension), persuasion (evoking
emotions to stimulate action), incentivization (an expectation
of rewards for behavior), coercion, (expectation of punitive
consequences and costs), training (transmitting skills),
restriction (using rules and regulation to reduce behavior),
environmental restructuring (modifying the physical or social
environment), modeling (providing an exemplar of behavior
for people to emulate), and enablement (increasing the means
to carry out the behavior) [27]. IFs can be further broken down
into strategies enabling behavior change labeled as BCTs,
representing the observable, replicable, and active ingredients
in an intervention that directly bring about behavior change
[28].
Methods
The app development process drew on the BCW for guidance
on understanding the target behavior of medication adherence
and how to address this behavior through the use of relevant
BCTs. The following section provides details of the steps taken
during this process.
Stage 1: Understanding the Behavior
The first stage involved a number of steps to understand the
behavior.
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Step 1: Defining the Problem
Stakeholder meetings with pediatricians along with a review of
the literature helped to define the problem.
Step 2: Selecting the Target Behavior
Stakeholder meetings helped to consider all potential
self-management behaviors. However, as previously noted, the
BCW recommends starting with only 1 or 2 target behaviors
and gradually building on these [22,27]. Selecting the target
behavior involved consultation with 2 pediatricians with
expertise in SCD and e-learning and a review of the literature.
Step 3: Specifying the Target Behavior
The behavior was then specified for this target population in
terms of the context in which the target behavior occurs.
Step 4: Identifying What Needs to Change
This step involved conducting empirical research using a
qualitative research design guided by the COM-B model [29]
and Theoretical Domains Framework (TDF [30,31]) to explore
barriers and enablers to patients’ capability, opportunity, and
motivation toward medication adherence. The TDF is a
framework that amalgamates central theoretical constructs from
a wide range of behavior change theories. It classifies 14
significant domains such as skills and emotion, which influence
behavior and are possible targets for change [31]. The TDF can
be demarcated into 3 core elements of human behavior:
capability (C), opportunity (O), and motivation (M) [32]. The
COM-B model purports that behavior (B) is a consequence of
the interactions between a person’s physical and psychological
capabilities (C) to utilize social and environmental opportunities
(O) via automatic or reflective motivations (M) [33]. The
qualitative research involved conducting 10 interviews with
children and adolescents with SCD.
Participants
Patients were recruited through Charité University Hospital,
Department of Pediatric Hematology and Oncology. All patients
were considered eligible if they suffered from SCD, were treated
with hydroxycarbamide, owned a smartphone, and were aged
between 12 and 18 years. They were invited to take part in the
development of an app at the end of their routine face-to-face
consultation with the pediatrician. Upon agreement, patients
were then telephoned to arrange a time to conduct the interview.
Information on demographics, technology use, and smartphone
ownership was collected before the interviews (see Results
section). Ongoing analysis was conducted across interviews
until it became clear that no new codes were emerging from the
data, and therefore, recruitment for new participants ceased
[34].
Procedure
Interviews took place in a private room in the hospital where
parent informed consent and child informed consent were
obtained where necessary, before interviews commenced.
Participants were paid 30 euros for their participation in the
research. A non-native German speaking female interviewer
(37 years old) conducted the interviews lasting 30 min. The
interviews consisted of semi-structured questions (see Table 1
for the schedule of topics) developed from a review of existing
research [5,9,35-37] and structured using the COM-B and TDF
to explore barriers and enablers to patients’ capability,
opportunity, and motivation to self-manage their condition, with
a focus on medication adherence. For example, the TDF domains
of memory, attention, and decision-making processes included
questions such as “What are your thoughts on how well you
remember to take your medication”, and environmental context
and resources included questions such as “What are your
thoughts on the things in your environment that make it difficult
to take your medication?” Upon permission of the participants,
the interviews were audio-recorded, transcribed, and translated
into English for analysis.
Thematic Analysis of the Interview Data
Demographic data were analyzed using descriptive statistics.
Transcripts were analyzed by 2 independent researchers using
recognized principles for conducting thematic analysis [38].
This involved deductively coding the data for their basic
meaning before mapping to the COM-B and TDF. This analysis
helped to perform a behavioral analysis of the problem wherein
theoretical domains were identified as targets for change [29].
In addition, the reliability of the qualitative data was further
enriched by the use of an additional trained qualitative researcher
who was familiar with the BCW framework and TDF, who
independently coded 10% of the data to establish interrater
reliability. An agreement of 11/14 TDF domains were
established on discussion, and full agreement was reached. An
interrater reliability of .79 is generally considered to be an
acceptable rate [39].
Stage 2: Identifying Intervention Strategies
Step 5: Identifying Intervention Functions
According to Michie et al, the behavioral diagnosis drawn from
the COM-B and TDF tools for understanding the behavior
represents the foundations for intervention design. Once the
profile of COM-B and TDF domains has been identified as
important levers for change, the next stage is to select from a
range of IFs provided by the BCW framework [27].
The BCW framework provides a table mapping relevant IFs
likely to bring about change in specific COM-B and TDF
domains to help conduct this task. However, it was also
necessary to review the BCTs that the BCW has mapped to IFs
to see how they align with the TDF domains identified.
Therefore, the mapping process underwent a cyclical process
where BCTs were mapped back to IFs. The next step involves
delineating these IFs into specific BCTs. The authors of the
guide purposely used the term functions to indicate that BCTs
can have more than 1 IF [27].
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Table 1. Schedule of questions for interviews.
Topic questionCOM-Ba model and TDFb
Psychological capability
Knowledge • What are your thoughts on how much you know about Sickle Cell Anemia (Prompt:
Can you describe what it is?)
• What are the complications of the condition?
• How is the condition treated?
• How does the medication (specify which one) for the condition work?
Skills • Do you know how to take your medication?
• What are your thoughts on any measures that you can take to prevent the condition
getting worse?
Memory, attention, and decision-making processes • What are your thoughts on how well you remember to take your medication?
• Do you normally set a reminder to take your medication?
Behavioral regulation • Do you have a way of monitoring whether you have taken your medication every
day? (If no, why not? If yes, how?)
Environmental context and resources • What are your thoughts on the things in your environment that make it difficult to
take your medication? (Prompt: lack of time, lack of privacy)
Social opportunity
Social influences • What are your thoughts on how much support you receive from your parents for
your condition?
• What kind of support do you receive from your local community?
• What kind of support do you receive from your close friends?
• What kind of support do you receive from your school/teachers?
• Do you have any further ideas on how family and friends can support you in an app?
Reflective motivation
—
cSocial identity
Beliefs about capabilities • How confident do you feel about managing your condition? (Prompt: remembering
to take your medication, managing your moods, managing the pain)
—Optimism
Beliefs about consequences • What do you believe might happen to your body if you take your medication?
(Prompts: what are your beliefs on whether medication will make your illness worse
or better?)
• What are your thoughts around side effects?
• What are your thoughts around how serious your condition is?
• What are your thoughts on whether it takes too much time and effort to take your
medication during your daily routine?
Intention • Do you intend to take your medication every day? (Prompt: If not, why not?)
Goals • What are your thoughts on your goals for taking medication?
Automatic motivation
Reinforcement • What would be an incentive to take your medication?
• We have had some ideas of how features in an app can help to incentivize children
to take their medication
Emotion • What are your thoughts on whether your moods make your physical symptoms worse
or better? How could the app help you to manage your moods better?
• Does taking your medication cause any emotional reactions and feelings?
aCOM-B: Capability Opportunity, Motivation-Behavior.
bTDF: Theoretical Domains Framework.
cNot applicable.
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Step 6: Identifying Behavior Change Techniques
Mapping BCTs to intervention functions involved 2 steps: First,
the BCW table for mapping IFs to relevant BCTs provided a
candidate list of BCTs to use for the intervention. As previously
mentioned, selecting IFs also required looking forward to
ascertain which BCTs that the BCW maps to IFs aligned with
the TDF domains and context of an app. Therefore, some BCTs
were already selected if they were relevant to bringing about
change in the TDF domain. This step also involved reviewing
a systematic review of medication adherence among pediatric
patients with SCD [5].
Step 7: Translating Findings Into App Features
Consultation with the project team in the form of a workshop
(app developers, pediatricians, and behavioral scientist) helped
to translate the intervention mapping results into app features.
The process involved the behavioral scientist (KC) presenting
key findings using the intervention mapping table to the project
team. Specifically, the table helped to communicate which BCTs
were required to change medication adherence behavior. This
then instigated discussions on how these techniques could be
operationalized in the app, leading to decisions on app features.
Further meetings via Skype also involved the design company
(comprised user experience experts) to help with the
development of engaging app features. Table 2 below presents
the sample demographics and mobile phone usage.
Table 2. Demographics and mobile phone information (N=10).
ValuesDemographics
Origins of parents (N=20), n (%)
7 (35)Lebanon
6 (30)Nigeria
3 (15)Angola
2 (10)Sierra Leonne
1 (5)The Congo
1 (5Palestine
Gender, n (%)
6 (60)Female
4 (40)Male
14 (11-17)Age (years), mean (range)
8 (80)German citizenship, n (%)
Living status, n (%)
9 (90)Not living alone
4 (3-6)Number of people living in household, average (range)
Parents’ employment status, n (%)
5 (56)Mothers unemployed (n=9)
4 (44)Mothers employed full time (n=9)
4 (57)Fathers employed full time (n=7)
2 (29)Fathers employed part time (n=7)
1 (14)Fathers self-employed (n=7)
10 (100)Smartphone ownership and access to the internet, n (%)
Frequency of mobile phone use, n (%)
9 (90)Daily
1 (10)2-3 times a week
Results
Step 1: Defining the Problem
The problem was defined by the stakeholder group as too many
children and adolescents with SCD not successfully
self-managing their condition.
Step 2: Selecting the Target Behavior
Pediatricians reported that medication nonadherence was a
serious problem among their patients. This was also bolstered
with systematic review evidence indicating medication
adherence is low among young people, resulting in detrimental
effects to their health [5-7]. Therefore, supporting children and
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adolescents with their medication adherence was identified as
the target behavior.
Step 3: Specifying the Target Behavior
The global term, medication adherence, incorporates initiating
the prescription, actual dosing in relation to the prescription,
and persisting with treatment. Adherence relates simply to the
behavior itself—using treatment at the right time, for the right
period, in the right quantity, and in the right manner [40]. Table
3 below specifies the target behavior by detailing who needs
perform the behavior, when, where, how and with whom.
Step 4: Identifying What Needs to Change
The behavioral analysis (shown in Table 4) revealed barriers
and enablers in all 3 COM-B domains and the following 10
TDF domains involving the following: limited knowledge
related to the disease itself and how the mediation works
(knowledge); Forgetting to take medication and set reminders
(memory, attention, and decision processes); lack of external
monitoring and reminders (behavioral regulation); limited
confidence related to medication adherence (beliefs about
capabilities); limited importance of regular medication
adherence, priority for other influences on health such as religion
and negative consequences on taste and social life (beliefs about
consequences); perceived limited support required during the
transition to adulthood (social identity); intrinsic goals such as
excelling at sports provided motivation to medication adherence
(goals); emotional responses to taking medication and managing
pain (emotion); perceived limited time to take medication, being
outside of the home environment and other health professionals
(environmental context and resources); and an over reliance on
parents to remember to take medication and importance of peer
support (social influences). The subthemes taken forward for
intervention development are highlighted in italics in Table 4
below.
Steps 5, 6, and 7: Intervention Mapping Table
The intervention mapping table shown below (Table 5) shows
the mapping of determinants, intervention strategies, and
potential app features. This is where the results from the COM-B
and TDF analysis were mapped onto 15 BCTs as guided by the
BCW.
Table 3. Specifying the target behavior.
Medication adherenceTarget behavior
Children and young people with sickle cell diseaseWho needs to perform the target behavior?
Every day (at a time suitable for their schedules)When do they need to perform the behavior?
At home and outside of the homeWhere do they need to perform the behavior?
Once a dayHow often do they need to perform the behavior?
By themselves (or parents)With whom do they need to perform the behavior?
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Table 4. Behavioral analysis of the influences on patients’ medication adherence. Subthemes in italics were taken forward for intervention development.
QuoteCOM-Ba model, TDFb, and subtheme
Psychological capability
Knowledge
I don’t have the same stamina, as other teenagers of my age. I have to
dress warmly in the winter, or else I’ll have pain. I’m more susceptible
Perceived good knowledge of self-management of condition
when I do sports, I’m not supposed to overexert myself, I can get injured
quickly. My hips are inflamed because of overexertion during sports [P10].
You have to go see Dr. Lobitz every 3 months, once a year an annual
check-up, when they run all the tests. I also have to take penicillin every
Perceived good knowledge of task/environment “what to do”
morning and every evening, and Siklos every evening, and Ibuprofen when
I’m in pain [P10].
Don’t know [P2].
It’s a medication for not having pain. If you don’t drink enough, this pill
helps [P3].
Limited knowledge in relation to how the medication
works—scientific rationale
Not so much. There are these white blood cells that get into your bones
[P4].
Limited disease knowledge
Skills
1 ½ film-coated tablets every day. You can take them in the morning or
in the evening [P6].
Good knowledge and skills in relation to how to take the medica-
tion
I’m more susceptible when I do sports, I’m not supposed to overexert
myself, I can get injured quickly. My hips are inflamed because of
overexertion during sports [P10].
...dressing warmly, if you’ve been swimming, put a towel on right away
[P2]
Good knowledge and skills in relation to prevention
Memory, attention, and decision-making processes
It’s just something I do, take a pill before I go to bed. It’s become my
routine. If I’m on a school trip or spending the night at a friend’s house,
I also bring it along and take it [P9].
Medication taking is part of a routine
Sometimes I forget, pretty often, actually. My mom helps me remember,
my dad and my sister too [P2].
Very poorly. I need this app. I always forget [P6].
Forgetting to take medication
Yes, I set the alarm clock on my cell phone for nine, for example. It helps,
but sometimes I forget to set the alarm clock [P2].
Forgetting to set external reminders
Behavioral regulation
No – I haven’t ever considered it [P5].Lack of external monitoring device for medication intake
Reflective motivation
Intentions
It goes without saying. In the morning I wake up, I take my penicillin and
I go out. In the evenings it’s also like that, I just take them. If I’m spending
High intentions and adherence to morning and evening medication
intake
the night at a friend’s house, I take the medications first and then I go to
my friend’s house [P10].
Beliefs about capabilities
Very confident. I’m old enough to know what I have to do [P2].
50/50. Taking my medication is the only problem I have [P6].
Self-confidence: high and moderate confidence in relation to how
well they can self-manage the condition
Beliefs about consequences
Skipping it one day is not a biggie, but if you don’t take it for several
months, you’ll get weaker, you’ll feel worse, you’ll have no more strength
or energy. The pain will probably also get worse [P10]
If I don’t take my medication, it doesn’t make any difference [P6].
High and low importance and relevance to the perceived conse-
quences of nonadherence to treatment
Then my mother told me, God will not let you die at the age of 40 because
you haven’t taken your medication [P6].
Religion has a greater importance compared with medication
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QuoteCOM-Ba model, TDFb, and subtheme
XXX is uncomfortable to swallow. It doesn’t have any taste, but it starts
dissolving in your mouth, that’s a disgusting feeling [P10].
Thoughts on medication intake negative consequences (physical)
It bothers me when I’m at a friend’s house, and we’re talking, and then I
have to break up the conversation to say, I have to take my pill now. That’s
annoying [P8].
Thoughts on medication intake negative consequences (social)
Social identity
I am older and I can manage [P10].Personal identity
Goals
I have a goal, to be able to be the best I can be at sports. That’s my moti-
vation [P10].
Clear goals driving intrinsic motivation
Automatic motivation
Reinforcement
...if you skip it more often, you can get sick [P5].Physical consequences of not taking medication long term
I always remember, it’s a question of habit [P3].Remembering to take medication is easier when it becomes a
habit
I put the pills somewhere where I’ll see them right away, someplace where
I’ll definitely see them this evening. That works well [P9].
The home environment
Emotions
There’s no connection. When I have pain, I just take medication; I always
feel the same [P10].
Thinking of good things helps when you’re in pain [P7].
When something bad happens, pain gets worse [P2].
Variation in beliefs toward the connection between emotions and
pain
It sometimes makes me sad, because I don’t want to be taking medicine,
but I have to [P7].
Negative emotion toward medication taking
Social opportunity
Social influences
My friends know about my condition. They send me messages on WhatsApp
when I’m sick. When I write to my class on WhatsApp that I’m sick and
not coming to school, they all write to me and tell me to get better. This
makes me happy [P1].
Peer support during unwell periods
If I’m watching TV, my mother comes and tells me I should take my medi-
cation [P7].
They help me. They prepare my medication for me so that I can take it
quickly and get on doing other things in my daily routine [P3].
Practical parental support for taking medication
But home when I’m with my mom, I can be like, “Aaa mama I have this
stomach ache!” [P6].
Emotional parental support for pain crises
My mother accompanies me sometimes to my appointments with Dr XXX.
Gradually she’s been helping me less and less, I’m old enough already.
We’ve both decided that I can go to those appointments on my own [P10].
(Minimal) parental support only important support explicitly
perceived as needed (older children)
If I’m staying at a friend’s house late, I take my medication with me and
my friends tell me when to take it [P7]; If we’re in PE, they tell me to sit
down and tell the teacher if I’m not feeling well. When we go swimming,
they come out of the water with me and go with me to fetch something to
eat and drink, because I’m not supposed to stay in the water for too long.
They ask me whether I’ve taken my medication [P5].
Peer support for medication adherence and management of
condition
Physical opportunity
Environmental context and resources
When I have to get dressed quickly and go to school, my school is far
away, I have to do everything quickly. I don’t have enough time and then
I forget [P2].
Limited time to take medication
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QuoteCOM-Ba model, TDFb, and subtheme
When I come home from the street, I don’t think about it [P6]; If I’m out
and about or if I have to take it at a different time [P2]; When I’m at a
friend’s house, every once in a while I forget to take my medication [P5].
Being outside of the home environment
When [my regular] doctors aren’t there, the others don’t know how to
treat me [P7].
Other health professionals
aCOM-B: Capability Opportunity, Motivation-Behavior.
bTDF: Theoretical Domains Framework.
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Table 5. Final intervention mapping table.
App featuresBehavior change techniquesIntervention functionsCOM-Ba model, TDFb and subtheme
Psychological capability
Knowledge
Quiz, mood trackerInformation about an-
tecedents, self-monitoring
of behavior
EducationPerceived disconnection between thoughts
and moods and effects on their condition
Quiz related to biological causes of
sickle cell disease and effects of medi-
cation
Information about health
consequences
EducationLimited knowledge in relation to how the
medication works—scientific rationale
MADMPc
Medication remindersPrompts/cuesEnvironmental restruc-
turing
Forgetting to take medication
Behavioral regulation
Medication diary. Record how many
tablets they have taken each day and
Self-monitoring of the behav-
ior, feedback on the behav-
ior, social support (practical)
Environmental restruc-
turing
Perceived behavioral control: Not using
external monitoring device for medication
intake when they have missed one. Buddy
messenger—A chosen close friend can
also monitor medication adherence and
send a reminder them to take medica-
tion
Reflective motivation
Beliefs about consequences
Quiz, persuasive messages (in-app no-
tifications). Explain that not taking
Information about health
consequences
EducationLittle importance and relevance of the per-
ceived consequences to medication adher-
ence (religion) medication can result in a pain crises
and serious complications
Quiz, tipsProblem solvingEnablementNegative consequences on medication in-
take (physical)
Quiz, tipsProblem solvingEnablementThoughts on medication intake negative
consequences (social)
Quiz, tipsInformation about health
consequences, problem
solving
Education enablementPerceived limited time to take medication
Medication reminders, tipsProblem solving,
prompts/cues
Environmental restruc-
turing enablement
Self-confidence in remembering to take
medication
Social Identity
Quiz, tips, patients’ stories on how they
are coping with their condition. Users
Information about health
consequences, problem
Education, modellingPersonal identity, transition to adulthood
can view each other’s avatars to seesolving, social comparison,
modeling how many points they have for medica-
tion adherence and appointments
Patients stories on how they are coping
with their condition
Social comparison, model-
ing
ModelingGroup identity (interest in how other pa-
tients are coping)
Goals
Encourage them to set their own goals
for taking their medication (prompt: so
Goal setting (outcome)PersuasionClear goals driving intrinsic motivation
they can take part in sports, hang out
with friends)
Automatic motivation
Emotion
Comical anecdotes (jokes) and videos
to distract from the pain, relaxation
videos, and audios
Reduce negative emotions,
Practice habit formation
EnablementConnection between stress and pain
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App featuresBehavior change techniquesIntervention functionsCOM-Ba model, TDFb and subtheme
Comical anecdotes (jokes), other pa-
tient stories on how they manage their
medication adherence, messages to
friends, encourage them to make a plan
of how to take medication when they
are socializing
Reduce negative emotions,
Social support, Problem
solving, Action planning
Enablement, modelingNegative emotion toward medication taking
(reliance and interference with social activ-
ities)
Social Opportunity
Social influences
Tips. Advise to call or text a friend
when they need to distract from the
pain
Social support (practical and
emotional)
Environmental restruc-
turing, enablement
Peer support
Physical opportunity
Environmental context and resources
Tips. Advise to keep their medication
on show in a place in their home they
will see it
Add objects to the environ-
ment
Environmental restruc-
turing
The home environment
Medication reminders, encourage a
plan to take medication when going out
socially, instruct the person to practice
taking medication in a social context
Prompts/cues, Action plan-
ning, Behavioral practice
Environmental restruc-
turing, enablement
Outside of the home environment
Health recordAdding objects to the envi-
ronment
Environmental restruc-
turing, enablement
Other health professionals
aCOM-B: Capability Opportunity, Motivation-Behavior.
bTDF: Theoretical Domains Framework.
cMemory, attention, and decision-making processes.
Overall Concept of MyMate&Me
The following app features were chosen for the first release:
Avatar (Figures 1 and 2)—a cartoon figure of a boy or girl
accompanies the patient throughout his or her interaction with
the app. The patient is encouraged to earn bonus points through
being active in various app sections to dress the avatar with new
clothes, accessories, or even facial hair. Tip of the day (Figure
3)—important information on day-to-day coping with the
disease, sometimes providing gender-specific tips and dispelling
myths. Daily Quiz (Figure 4)—points can be earned for
answering quiz questions correctly. If a quiz question is
answered incorrectly, the right answer is provided, increasing
the patient’s awareness of different aspects of his or her disease.
Mood Tracker (Figure 5)—Users can tilt the phone to indicate
which mood they are in. Medication and Appointment Reminders
(Figure 6)—points are earned for confirming that medication
has been taken and appointments have been kept. Patients can
see the avatars of other patients using the app and compare their
scores. Emergency section (Figure 7)—includes crucial
information for health professionals unfamiliar with the disease
and quick emergency call and text options.
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Figure 1. Avatar.
Figure 2. Avatar with clothes options.
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Figure 3. Tip of the Day.
Figure 4. Daily Quiz.
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Figure 5. Mood Tracker.
Figure 6. Medication Reminder.
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Figure 7. Emergency card.
Discussion
Principal Findings
Previous research in relation to medication adherence supports
the findings in this study, indicating that nonadherence can
result from forgetting [40], children disliking the taste [41], and
the transition from childhood to adulthood [35]. Chronic
illnesses affect young people in a myriad of different ways as
they transition into adulthood and adult care [8]. Parents have
been largely responsible for ensuring their children self-manage
a chronic condition such as taking their medication [8].
Furthermore, evidence suggests that parents’ perceptions of
whether the medication will work also predicts medication
continuity which aligns with the religious influence on
medication adherence reported by one of the participants [42].
Previous research suggests that parents are concerned with their
child’s transition into adulthood where there is a need for
children to take more control and responsibility toward their
condition and to self-manage [33]. Patients need to be able to
self-monitor their medication adherence and self-manage their
condition as they grow older, and this can supported in the
MyMate&Me app through features that enable reminders,
self-monitoring, feedback on their behavior, support from peers,
and problem solving.
In line with previous research, some participants reported that
their mood, stress, and anxiety exacerbated their pain symptoms
as reported in previous research with this population [13]. This
research also provides new insights among older children where
they reported negative emotions around their reliance on
medication and its interference with social activities.
Furthermore, being outside of the home environment was also
cited as a barrier to medication adherence: there were no
environmental cues to remind them to take their medication
and/or a lack of suitable places to take them in privacy.
Theoretical domains targeted for change were mapped onto 15
BCTs which also align with the components for
self-management proposed in the Practical Reviews In
Self-Management Support (PRISMS) taxonomy [43]. Although
many of these BCTs have been found collectively across
medication adherence apps on the market, individual apps have
only been underpinned with 2 to 3 of these BCTs. In addition,
most have only used Action planning and a Prompt/cue. This
study also highlighted the need for BCTs: Goal setting
(outcome), Problem solving, and Reducing negative emotions,
which are missing in the review of medication apps [22].
Strengths of the Research
Drawing on a theoretically grounded and evidenced-based
intervention development framework, along with conducting
research with the target audience, has resulted in the first
theory-and-evidence-based app for medication adherence for
children and adolescents with SCD. The findings have
highlighted barriers that go beyond simply forgetting to take
their medication (as focused on in current SDC medication
adherence apps), where emotions and social life are perceived
to play a pivotal role in medication adherence, particularly
during the transition from childhood to adulthood.
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Limitations of the Research
The empirical research engaged a small purposive sample.
Consequently, the identified views on the facilitators and barriers
to medication adherence may be less representative of other
young people with SCD. However, qualitative research may
not require a high number of participants before reaching data
saturation, and randomization is more suited to quantitative
inquiry [44]. The qualitative approach followed, enabled a richer
reflection of the barriers and facilitators to the target behavior,
and assessed the contribution of the sociocognitive and external
factors influencing the target behavior. In addition, the age range
of participants may be considered as too wide, raising concerns
about the study’s ability to capture the different issues relating
to medication adherence. However, the qualitative nature helps
to overcome this by allowing participants to give an in-depth
account of their experiences.
There are also a number of limitations with the application of
the BCW approach. Selecting which BCTs to use in the
intervention represented a challenging process as the BCT (v1)
at the time of research did not link individual BCTs to their
theoretical determinants. However, recently, a Web-based tool
has been launched to support this process and specifically links
BCTs with theoretical determinants known as mechanisms of
action [45]. However, as noted by Orji and Mandryk, using a
mapping process for intervention development, is always subject
to interpretation [46]. The process of selecting IFs was
challenging because many of the same BCTs belonged to
different IFs. However, the IM table was reviewed by 2 health
psychologists to help overcome these challenges.
Future Research
The app is now undergoing formal usability testing with patients.
In addition, nonintrusive data collection such as usage data of
app features (which correspond with BCTs) and their correlation
to behavior change will help to measure engagement with the
intervention as proposed in other mHealth research [47].
Conclusions
Patients with SCD have complex barriers to medication
adherence which can only be identified in using comprehensive
enough models and frameworks of human behavior such as the
COM-B and TDF. As such, existing apps lacking a theoretical
underpinning do not go far enough in supporting young people
with SCD; focusing only on 1 or 2 aspects of medication
adherence such as reminders and medication logs.
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